National Summit on Preventing Pharmaceutical Waste October 19, 2010 University of the Sciences...
-
Upload
leslie-bates -
Category
Documents
-
view
214 -
download
0
Transcript of National Summit on Preventing Pharmaceutical Waste October 19, 2010 University of the Sciences...
Prepared by the Product Stewardship Institute 1
National Summit on Preventing Pharmaceutical Waste
October 19, 2010University of the Sciences Philadelphia, Pennsylvania
October 19, 2010
Prepared by the Product Stewardship Institute 2
Who is PSI?
October 19, 2010
Non-profit founded in 2000 Membership
46 States 170+ Local governments 55+ Corporate, Organizational, Academic
Partners
Board of Directors: 7 states, 4 local agencies
• Multi-stakeholder product stewardship network
What is Product Stewardship?
“Product Stewardship" is a principle
that directs all those involved in the life
cycle of a product to take shared
responsibility for reducing the health
and environmental impacts that result
from the production, use, and end-of-
life management of the product.
Prepared by the Product Stewardship Institute 4
Pharmaceuticals Initiative
• National Dialogue Meeting #1 – June 2008• National Dialogue Meeting #2 – Dec 2008– Suggestion for a summit on waste reduction– SR Workgroup at the time: organizations,
pharmaceutical companies, EPA, state gov’t• Workgroup focused on Controlled Substances
Act change
October 19, 2010
Prepared by the Product Stewardship Institute 5
“Source Reduction” Focus
• Qualitative research under Dr. Becker’s study– Florida Department of Environmental Protection
• Workgroup helped to develop agenda• Partnership with WHEN on developing
educational modules also under EPA Region 3 project
October 19, 2010
Prepared by the Product Stewardship Institute 6
PSI’s Role
• Creating a forum & facilitating discussion• Listening for potential action items, policy
ideas• Summarize what we hear at the meeting– Circulate for review
• Next steps?
October 19, 2010
Prepared by the Product Stewardship Institute 7
Participants’ Role
• Ask questions• Share information/perspectives• Think outside the box• Be specific–Multiple contexts represented
October 19, 2010
Prepared by the Product Stewardship Institute 8
Agenda:
October 19, 2010
Time Session Presenters9:00 am Introductions and Welcome Andrew Peterson, PharmD, PhD
University of the Sciences in Philadelphia9:20 am Purpose of the Meeting
Introduction to PSI Background on the issue Focus and goals for the meeting
Sierra Fletcher, PSI Joel Kreisberg, DC, MA
Teleosis Institute
10:00 am BREAK10:20 am Preventing Waste from Unused Prescriptions: Short-cycle
dispensing, building co-pays & other options Overview of the issue & stakeholder considerations MaineCare initial prescription limitation policy Discussion
Tracy McCutcheon, MHSA, MBACenters for Medicare & Medicaid Services
TBD
12:00 pm LUNCH
1:15 pm Preventing Waste from Drug Samples Overview of the issue and program experience Discussion
Catherine Zimmer, MS, BSMT Zimmer Environmental Improvement, LLC
2:15 pm Preventing Waste: Different stakeholders’ perspectives Research and potential policy options Discussion
Julie Becker, PhD, MPHWomen’s Health and Environmental Network
3:30 pm Next steps: Are there other strategies to discuss? Sierra Fletcher, PSI4:00 pm Adjourn Sierra Fletcher, PSI
Prepared by the Product Stewardship Institute 9
Goal• Develop public and corporate policy
recommendations to reduce the quantity of pharmaceuticals that are no longer wanted or needed in homes and healthcare facilities.
We seek to build on information and policy ideas from around the country and from different
perspectives.
October 19, 2010
Prepared by the Product Stewardship Institute 10
Focus of this Meeting
• Preventing waste by reducing the quantity of drugs that are no longer wanted or needed in homes and healthcare facilities.
October 19, 2010
This meeting will not address issues associated with drug disposal including mail-back or other take-back programs,
incineration, etc.
Prepared by the Product Stewardship Institute 11
Challenge
• Complexity of the “ecosystem”• Not “one-size-fits-all”• Momentum is towards getting people their
medicines as easily and cheaply as possible• These are not reasons to avoid developing
solutions
October 19, 2010
Prepared by the Product Stewardship Institute 12
Thank you to our meeting sponsors:
U.S. Environmental Protection Agency (Region 3)
Purdue Pharma L.P.
October 19, 2010
Prepared by the Product Stewardship Institute 13
Preventing Waste from Unused Prescriptions
• Overview of the issue & stakeholder considerations
• MaineCare initial prescription limitation policy• Discussion
October 19, 2010
Prepared by the Product Stewardship Institute 14
Questions• What are the pros and cons of short-cycle
dispensing?– Initial prescription limitations?
• Are there specific contexts in which this approach would be easier to implement?
• Voluntary? Mandated?• What would need to happen for this to be
widely adopted (if that’s what we want)?
October 19, 2010
Prepared by the Product Stewardship Institute 15
Questions• Should it apply to all medicines? – Only those with higher discontinuation rates?– Only those most likely to be abused?– To what extent does this depend on the context?
• What are the options for pro-rating co-pays?• What would be the best possible scenario?• Are there any next steps on this topic?– Other information?– Other stakeholders?
October 19, 2010
Prepared by the Product Stewardship Institute 16
Thank you to our meeting sponsors:
U.S. Environmental Protection Agency (Region 3)
Purdue Pharma L.P.
October 19, 2010
Prepared by the Product Stewardship Institute 17
Samples/Vouchers: Questions• How can we minimize clinic sample waste?• How can we encourage the use of vouchers in
place of samples?• What are the pros and cons?• How/can this work in other contexts?• Voluntary? Mandated?• What would need to happen for this to be
widely adopted (if that’s what we want)?
October 19, 2010
Prepared by the Product Stewardship Institute 18
Thank you to our meeting sponsors:
U.S. Environmental Protection Agency (Region 3)
Purdue Pharma L.P.
October 19, 2010
Prepared by the Product Stewardship Institute 19
One more time…
• What are the pros and cons?• Are there specific contexts in which this
approach would be easier to implement?• Voluntary? Mandated?• What would need to happen for this to be
widely adopted (if that’s what we want)?
October 19, 2010
Prepared by the Product Stewardship Institute 20
Next steps?
• Additional information?• Strategies?• People?• Forums?
October 19, 2010